Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease
Journal of Molecular Endocrinology · 01.01.2026 · 76 (1)
DOI: 10.1530/jme-25-0080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Endocrinology, online erschienen am 23.12.2025. Verfasst von Hee Joo Yoon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Interleukin-11, Graves Ophthalmopathy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Thyroid eye disease (TED), a major extrathyroidal manifestation of Graves’ disease, is driven by the underlying autoimmune responses. This study aimed to elucidate the pathological role of IL-11 in TED and evaluate the therapeutic potential of LASN01, a potent, fully human antibody that targets IL-11 receptor alpha (IL-11Rα). IL-11 (P < 0.001) and IL-11Rα (P = 0.003) mRNA were significantly elevated in TED orbital tissues (n = 15) compared to normal controls (n = 15) by quantitative real-time polymerase chain reaction (RT-qPCR). IL-11 expressions in both TED and normal orbital fibroblasts (OFs) were upregulated after treatment with either transforming growth factor-beta (TGF-β) or insulin-like growth factor 1 (IGF-1). Furthermore, IL-11 exerted a synergistic stimulatory effect on hyaluronan production in TED OFs when combined with either TGF-β (3.21-fold, P < 0.001) or IGF-1 (2.83-fold, P < 0.001). Notably, the combination of IL-11 and TGF-β induced greater procollagen production (6.17-fold, P < 0.001). Blocking IL-11R with LASN01 effectively reduced both hyaluronan (94% reduction, P < 0.001) and procollagen production (36% reduction, P = 0.002) in ELISA under various stimulation conditions. Finally, Western blot analysis showed that LASN01 blocked STAT3 and ERK phosphorylation in TED OFs, which are known as downstream effectors of IL-11 signaling. This study systematically analyzed how IGF-1 and TGF-β promote IL-11 expression in OFs and examined the downstream effects of IL-11 on hyaluronan and procollagen production, highlighting the central role of IL-11 in TED-associated tissue expansion and fibrosis. The inhibitory effects of LASN01 on hyaluronan and procollagen production suggest that targeting IL-11R could represent an effective therapeutic option for TED, providing a foundation for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yonsei University College of Medicine, Seoul, Korea.
- Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.
- Shiley Eye Institute, University of California San Diego, San Diego, California, USA.
- Lassen Therapeutics Inc., San Diego, California, USA.
ORCID-Profile: Jin Sook Yoon
Zitieren
APA
Yoon, H. J., Park, H. Y., Kim, J. Y., Choi, S. H., Kikkawa, D. O., Swaney, J. S., King, D. J., Vasquez, Y. M., & Yoon, J. S. (2026). Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease. Journal of Molecular Endocrinology, 76(1). https://doi.org/10.1530/jme-25-0080
Vancouver
Yoon HJ, Park HY, Kim JY, Choi SH, Kikkawa DO, Swaney JS, et al. Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease. Journal of Molecular Endocrinology. 2026;76(1). doi:10.1530/jme-25-0080
BibTeX
@article{Yoon2026,
author = {Yoon, Hee Joo and Park, Hyun Young and Kim, Ji-Young and Choi, Soo Hyun and Kikkawa, Don O and Swaney, James S and King, David J and Vasquez, Yasmin M and Yoon, Jin Sook},
title = {Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease},
journal = {Journal of Molecular Endocrinology},
year = {2026},
volume = {76},
number = {1},
doi = {10.1530/jme-25-0080}
}
EUVIMED